Your browser doesn't support javascript.
loading
Impact of a third dose of anti-SARS-CoV-2 vaccine in hematopoietic cell transplant recipients: A Japanese multicenter observational study.
Mori, Yasuo; Uchida, Naoyuki; Wake, Atsushi; Miyawaki, Kohta; Eto, Tetsuya; Nakamura, Takayuki; Iwasaki, Hiromi; Ito, Yoshikiyo; Tanimoto, Kazushi; Katayama, Yuta; Imamura, Yutaka; Takahashi, Tsutomu; Fujisaki, Tomoaki; Kamimura, Tomohiko; Choi, Ilseung; Ishitsuka, Kenji; Yoshimoto, Goichi; Ogawa, Ryosuke; Sugita, Junichi; Takamatsu, Yasushi; Tanimoto, Kazuki; Hidaka, Tomonori; Miyamoto, Toshihiro; Akashi, Koichi; Nagafuji, Koji.
  • Mori Y; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
  • Uchida N; Department of Hematology, Toranomon Hospital, Tokyo, Japan.
  • Wake A; Department of Hematology, Toranomon Hospital Kajigaya, Kawasaki, Japan.
  • Miyawaki K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
  • Eto T; Department of Hematology, Hamanomachi Hospital, Fukuoka, Japan.
  • Nakamura T; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan.
  • Iwasaki H; Departments of Hematology, National Hospital Organization, Kyushu Medical Center, Fukuoka, Japan.
  • Ito Y; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
  • Tanimoto K; Department of Hematology, Clinical Immunology, and Infectious Diseases, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Katayama Y; Department of Hematology, Hiroshima Red Cross Hospital and Atomic-Bomb Survivors Hospital, Hiroshima, Japan.
  • Imamura Y; Division of Hematology, St. Mary's Hospital, Kurume, Japan.
  • Takahashi T; Department of Hematology, Shimane University Hospital, Izumo, Japan.
  • Fujisaki T; Department of Internal Medicine, Matsuyama Red Cross Hospital, Matsuyama, Japan.
  • Kamimura T; Department of Hematology, Harasanshin Hospital, Fukuoka, Japan.
  • Choi I; Department of Hematology, National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan.
  • Ishitsuka K; Department of Hematology and Rheumatology, Kagoshima University Hospital, Kagoshima, Japan.
  • Yoshimoto G; Department of Hematology, Saga-Ken Medical Center Koseikan, Saga, Japan.
  • Ogawa R; Department of Hematology and Oncology, JCHO Kyushu Hospital, Fukuoka, Japan.
  • Sugita J; Department of Hematology, Hokkaido University Hospital, Sapporo, Japan.
  • Takamatsu Y; Division of Medical Oncology, Hematology and Infectious Diseases, Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
  • Tanimoto K; Department of Hematology, Fukuoka Red Cross Hospital, Fukuoka, Japan.
  • Hidaka T; Department of Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Miyazaki, Japan.
  • Miyamoto T; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan; Division of Hematology, Faculty of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University, Kanazawa, Japan.
  • Akashi K; Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Science, Fukuoka, Japan.
  • Nagafuji K; Division of Hematology and Oncology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan. Electronic address: knagafuji@kurume-u.ac.jp.
Vaccine ; 41(47): 6899-6903, 2023 11 13.
Article en En | MEDLINE | ID: mdl-37866994

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article